These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 33383047

  • 1. Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis.
    de Santiago PR, Blanco A, Morales F, Marcelain K, Harismendy O, Sjöberg Herrera M, Armisén R.
    Life Sci; 2021 Mar 01; 268():118956. PubMed ID: 33383047
    [Abstract] [Full Text] [Related]

  • 2. ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer.
    Song IH, Kim YA, Heo SH, Park IA, Lee M, Bang WS, Park HS, Gong G, Lee HJ.
    Tumour Biol; 2017 Oct 01; 39(10):1010428317734816. PubMed ID: 29022489
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D, Chen C, Wu J, Wang H, Wu D.
    Breast Cancer; 2019 Jan 01; 26(1):74-83. PubMed ID: 29974352
    [Abstract] [Full Text] [Related]

  • 7. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer.
    Wang W, Xie Y, Chen F, Liu X, Zhong LL, Wang HQ, Li QC.
    World J Gastroenterol; 2019 Aug 07; 25(29):3972-3984. PubMed ID: 31413531
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.
    Vlachogiannis NI, Sachse M, Georgiopoulos G, Zormpas E, Bampatsias D, Delialis D, Bonini F, Galyfos G, Sigala F, Stamatelopoulos K, Gatsiou A, Stellos K.
    J Mol Cell Cardiol; 2021 Nov 07; 160():111-120. PubMed ID: 34302813
    [Abstract] [Full Text] [Related]

  • 10. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
    Okugawa Y, Toiyama Y, Shigeyasu K, Yamamoto A, Shigemori T, Yin C, Ichikawa T, Yasuda H, Fujikawa H, Yoshiyama S, Hiro J, Ohi M, Araki T, Kusunoki M, Goel A.
    J Transl Med; 2018 Dec 18; 16(1):366. PubMed ID: 30563560
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of ADAR1 into the cytoplasm correlates with a better prognosis of patients with oral squamous cells carcinoma.
    Caponio VCA, Troiano G, Botti G, Pedicillo MC, Lo Russo L, Mastrangelo F, Ciavarella D, Losito NS, Aquino G, Nocini R, Santoro R, Santoro A, Lo Muzio L, Pannone G.
    J Oral Pathol Med; 2019 Feb 18; 48(2):108-114. PubMed ID: 30489667
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    Nakano M, Fukami T, Gotoh S, Nakajima M.
    J Biol Chem; 2017 Mar 24; 292(12):4873-4884. PubMed ID: 28188287
    [Abstract] [Full Text] [Related]

  • 14. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
    Liu X, Fu Y, Huang J, Wu M, Zhang Z, Xu R, Zhang P, Zhao S, Liu L, Jiang H.
    J Exp Clin Cancer Res; 2019 Jul 17; 38(1):315. PubMed ID: 31315644
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
    Zhu L, Cui K, Weng L, Yu P, Du Y, Zhang T, Liu H, Li B, Ma W.
    PLoS One; 2021 Jul 17; 16(6):e0249174. PubMed ID: 34086679
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells.
    Morales F, Pérez P, Tapia JC, Lobos-González L, Herranz JM, Guevara F, de Santiago PR, Palacios E, Andaur R, Sagredo EA, Marcelain K, Armisén R.
    Gene; 2022 Apr 20; 819():146246. PubMed ID: 35122924
    [Abstract] [Full Text] [Related]

  • 19. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
    Takeda S, Shigeyasu K, Okugawa Y, Yoshida K, Mori Y, Yano S, Noma K, Umeda Y, Kondo Y, Kishimoto H, Teraishi F, Nagasaka T, Tazawa H, Kagawa S, Fujiwara T, Goel A.
    Cancer Lett; 2019 Mar 01; 444():127-135. PubMed ID: 30583079
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.
    Zhang Q, Xiu B, Zhang L, Chen M, Chi W, Li L, Guo R, Xue J, Yang B, Huang X, Shao ZM, Huang S, Chi Y, Wu J.
    J Immunother Cancer; 2022 Oct 01; 10(10):. PubMed ID: 36252997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.